Insider Purchases: Inside the Buy

Tag: MED stock

Illustration of a Medifast turnaround showing a confident investor studying charts beside a cash reserve vault while a winding path labeled Trilivy climbs past GLP-1 headwinds, highlighting Medifast (MED) stock analysis and turnaround investing.

Medifast (MED) Stock Analysis: Can a Company Trading Below Its Cash Reinvent Itself?

Medifast (NYSE: MED) has nearly $170 million in cash, no debt, insider buying and a bold strategic pivot through Trilivy. But shrinking revenues and GLP-1 competition still cast a long shadow. Here's the complete bull vs. bear case.

Read entire article

Tags: FunStock Index, GLP-1, healthcare stocks, insider buying, investing, MED stock, Medifast, Medifast stock analysis, metabolic health, stock analysis, Trilivy, turnaround stocks, value investing, Wall Street, weight loss industry